BRD2 and cancer: Master regulatory proteins such as Brd2 are likely to belong to “critical paralog groups”—the subset of paralogs that are more central to signaling pathways, more varied in biological function and complex in post-transcriptional regulation, and more likely to be mutated in genetic diseases and cancer [69].